The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

Molecular Psychiatry (2019)Cite this article

Subjects

Abstract

In Alzheimer’s disease (AD), a single-nucleotide polymorphism in the gene encoding brain-derived neurotrophic factor (BDNFVal66Met) is associated with worse impact of primary AD pathology (beta-amyloid, Aβ) on neurodegeneration and cognitive decline, rendering BDNFVal66Met an important modulating factor of cognitive impairment in AD. However, the effect of BDNFVal66Met on functional networks that may underlie cognitive impairment in AD is poorly understood. Using a cross-validation approach, we first explored in subjects with autosomal dominant AD (ADAD) from the Dominantly Inherited Alzheimer Network (DIAN) the effect of BDNFVal66Met on resting-state fMRI assessed functional networks. In seed-based connectivity analysis of six major large-scale networks, we found a stronger decrease of hippocampus (seed) to medial-frontal connectivity in the BDNFVal66Met carriers compared to BDNFVal homozogytes. BDNFVal66Met was not associated with connectivity in any other networks. Next, we tested whether the finding of more pronounced decrease in hippocampal-medial-frontal connectivity in BDNFVal66Met could be also found in elderly subjects with sporadically occurring Aβ, including a group with subjective cognitive decline (N = 149, FACEHBI study) and a group ranging from preclinical to AD dementia (N = 114, DELCODE study). In both of these independently recruited groups, BDNFVal66Met was associated with a stronger effect of more abnormal Aβ-levels (assessed by biofluid-assay or amyloid-PET) on hippocampal-medial-frontal connectivity decreases, controlled for hippocampus volume and other confounds. Lower hippocampal-medial-frontal connectivity was associated with lower global cognitive performance in the DIAN and DELCODE studies. Together these results suggest that BDNFVal66Met is selectively associated with a higher vulnerability of hippocampus-frontal connectivity to primary AD pathology, resulting in greater AD-related cognitive impairment.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, et al. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA. 2008;105:2711–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Song M, Martinowich K, Lee FS. BDNF at the synapse: why location matters. Mol Psychiatry. 2017;22:1370–5.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Hall J, Thomas KL, Everitt BJ. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci. 2000;3:533–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol. 2001;63:71–124.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223–50.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2006;27:1372–84.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    de Wilde MC, Overk CR, Sijben JW, Masliah E. Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement. 2016;12:633–44.

    PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain. 2009;132(Pt 4):1067–77.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14:401–16.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Michalski B, Corrada MM, Kawas CH, Fahnestock M. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta. Neurobiol Aging. 2015;36:3130–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15:331–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Jiao SS, Shen LL, Zhu C, Bu XL, Liu YH, Liu CH, et al. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease. Transl Psychiatry. 2016;6:e907.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Nagahara AH, Mateling M, Kovacs I, Wang L, Eggert S, Rockenstein E, et al. Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J Neurosci. 2013;33:15596–602.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257–69.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Hao R, Qi Y, Hou DN, Ji YY, Zheng CY, Li CY, et al. BDNF val66met polymorphism impairs hippocampal long-term depression by down-regulation of 5-HT3 receptors. Front Cell Neurosci. 2017;11:306.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  16. 16.

    Petryshen TL, Sabeti PC, Aldinger KA, Fry B, Fan JB, Schaffner SF, et al. Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry. 2010;15:810–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, et al. BDNF Val66Met, Abeta amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiol Aging. 2013;34:2457–64.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, et al. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. PLoS One. 2014;9:e86498.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  19. 19.

    Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, et al. APOE and BDNF polymorphisms moderate amyloid beta-related cognitive decline in preclinical Alzheimer's disease. Mol Psychiatry. 2015;20:1322–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain. 2016;139(Pt 10):2766–77.

    PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease. Ann Neurol. 2018;84:424–35.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Kambeitz JP, Bhattacharyya S, Kambeitz-Ilankovic LM, Valli I, Collier DA, McGuire P. Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci Biobehav Rev. 2012;36:2165–77.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Harrisberger F, Spalek K, Smieskova R, Schmidt A, Coynel D, Milnik A, et al. The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data. Neurosci Biobehav Rev. 2014;42:267–78.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Park KH, Noh Y, Choi EJ, Kim H, Chun S, Son YD. Functional connectivity of the hippocampus in early- and vs. late-onset alzheimer's disease. J Clin Neurol. 2017;13:387–93.

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Allen G, Barnard H, McColl R, Hester AL, Fields JA, Weiner MF, et al. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol. 2007;64:1482–7.

    PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA. 2004;101:4637–42.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Tahmasian M, Pasquini L, Scherr M, Meng C, Forster S, Mulej Bratec S, et al. The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease. Neurology. 2015;84:1956–63.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. 28.

    Sorg C, Riedl V, Muhlau M, Calhoun VD, Eichele T, Laer L, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci USA. 2007;104:18760–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Pasquini L, Scherr M, Tahmasian M, Meng C, Myers NE, Ortner M, et al. Link between hippocampus' raised local and eased global intrinsic connectivity in AD. Alzheimers Dement. 2015;11:475–84.

    PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    La Joie R, Landeau B, Perrotin A, Bejanin A, Egret S, Pelerin A, et al. Intrinsic connectivity identifies the hippocampus as a main crossroad between Alzheimer's and semantic dementia-targeted networks. Neuron. 2014;81:1417–28.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  31. 31.

    Moulder KL, Snider BJ, Mills SL, Buckles VD, Santacruz AM, Bateman RJ, et al. Dominantly inherited Alzheimer network: facilitating research and clinical trials. Alzheimers Res Ther. 2013;5:48.

    PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Jones DT, Knopman DS, Gunter JL, Graff-Radford J, Vemuri P, Boeve BF, et al. Cascading network failure across the Alzheimer's disease spectrum. Brain. 2016;139(Pt 2):547–62.

    PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. JAMA Neurol. 2014;71:1111–22.

    PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, et al. FACEHBI: a prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. study rationale and research protocols. J Prev Alzheimers Dis. 2017;4:100–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE). Alzheimer's Res Ther. 2018;10:15.

    Article  Google Scholar 

  36. 36.

    Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367:795–804.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Franzmeier N, Duzel E, Jessen F, Buerger K, Levin J, Duering M, et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain. 2018;141:1186–1200.

    PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Suarez-Calvet M, Araque Caballero MA, Kleinberger G, Bateman RJ, Fagan AM, Morris JC, et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Sci Transl Med. 2016;8:369ra178.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  39. 39.

    Benzinger TL, Blazey T, Jack CR Jr., Koeppe RA, Su Y, Xiong C, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci USA. 2013;110:E4502–4509.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Lewczuk P, Matzen A, Blennow K, Parnetti L, Molinuevo JL, Eusebi P, et al. Cerebrospinal fluid Abeta42/40 corresponds better than Abeta42 to amyloid PET in Alzheimer's disease. J Alzheimers Dis. 2017;55:813–22.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, et al. CSF Abeta42/Abeta40 and Abeta42/Abeta38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3:154–65.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Lozoya-Delgado P, Ruiz-Sanchez de Leon JM, Pedrero-Perez EJ. [Validation of a cognitive complaints questionnaire for young adults: the relation between subjective memory complaints, prefrontal symptoms and perceived stress]. Rev Neurol. 2012;54:137–50.

    PubMed  PubMed Central  Google Scholar 

  43. 43.

    Alegret M, Espinosa A, Valero S, Vinyes-Junque G, Ruiz A, Hernandez I, et al. Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old. PLoS ONE. 2013;8:e76436.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, et al. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52:1210–7.

    PubMed  Article  PubMed Central  Google Scholar 

  45. 45.

    Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Monte-Rubio G, et al. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline. Sci Rep. 2018;8:3828.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  46. 46.

    Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Kent P. The evolution of the Wechsler Memory Scale: a selective review. Appl Neuropsychol Adult. 2013;20:277–91.

    PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Franzmeier N, Caballero MÁA, Taylor ANW, Simon-Vermot L, Buerger K, Ertl-Wagner B et al. Resting-state global functional connectivity as a biomarker of cognitive reserve in mild cognitive impairment. Brain Imaging Behav 2016;11:368–82.

  49. 49.

    Franzmeier N, Duering M, Weiner M, Dichgans M, Ewers M, Alzheimer's Disease Neuroimaging I. Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease. Neurology. 2017;88:1054–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci. 2003;23:6690–4.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol. 2018;17:241–50.

    PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Araque Caballero MA, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, et al. Mapping 3-year changes in gray matter and metabolism in Abeta-positive nondemented subjects. Neurobiol Aging. 2015;36:2913–24.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Pasquini L, Scherr M, Tahmasian M, Meng C, Myers NE, Ortner M et al. Link between hippocampus' raised local and eased global intrinsic connectivity in AD. Alzheimers Dement 2014;11:475–84.

  54. 54.

    Ebeling U, von Cramon D. Topography of the uncinate fascicle and adjacent temporal fiber tracts. Acta Neurochir (Wien). 1992;115:143–8.

    CAS  Article  Google Scholar 

  55. 55.

    Von Der Heide RJ, Skipper LM, Klobusicky E, Olson IR. Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. Brain. 2013;136(Pt 6):1692–707.

    Article  Google Scholar 

  56. 56.

    Anderson KL, Rajagovindan R, Ghacibeh GA, Meador KJ, Ding M. Theta oscillations mediate interaction between prefrontal cortex and medial temporal lobe in human memory. Cereb Cortex. 2010;20:1604–12.

    PubMed  Article  PubMed Central  Google Scholar 

  57. 57.

    Spaniol J, Davidson PS, Kim AS, Han H, Moscovitch M, Grady CL. Event-related fMRI studies of episodic encoding and retrieval: meta-analyses using activation likelihood estimation. Neuropsychologia. 2009;47:1765–79.

    PubMed  Article  PubMed Central  Google Scholar 

  58. 58.

    Grady CL, McIntosh AR, Craik FI. Age-related differences in the functional connectivity of the hippocampus during memory encoding. Hippocampus. 2003;13:572–86.

    PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    Axmacher N, Schmitz DP, Wagner T, Elger CE, Fell J. Interactions between medial temporal lobe, prefrontal cortex, and inferior temporal regions during visual working memory: a combined intracranial EEG and functional magnetic resonance imaging study. J Neurosci. 2008;28:7304–12.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  60. 60.

    Harris AZ, Gordon JA. Long-range neural synchrony in behavior. Annu Rev Neurosci. 2015;38:171–94.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  61. 61.

    Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage. 2006;31:496–504.

    PubMed  Article  PubMed Central  Google Scholar 

  62. 62.

    Zhang Y, Simon-Vermot L, Araque Caballero MA, Gesierich B, Taylor AN, Duering M, et al. Enhanced resting-state functional connectivity between core memory-task activation peaks is associated with memory impairment in MCI. Neurobiol Aging. 2016;45:43–49.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  63. 63.

    Henseler I, Falkai P, Gruber O. Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J Psychiatr Res. 2010;44:364–72.

    PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry. 2005;62:379–86.

    PubMed  Article  PubMed Central  Google Scholar 

  65. 65.

    Alvarez-Salvado E, Pallares V, Moreno A, Canals S. Functional MRI of long-term potentiation: imaging network plasticity. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130152.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  66. 66.

    Boots EA, Schultz SA, Clark LR, Racine AM, Darst BF, Koscik RL, et al. BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention. Neurology. 2017;88:2098–106.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM, et al. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci. 2009;29:9321–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, et al. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS ONE. 2009;4:e5424.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  69. 69.

    Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, et al. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. Int Psychogeriatr. 2017;29:1825–34.

    PubMed  Article  PubMed Central  Google Scholar 

  70. 70.

    Krasnow B, Tamm L, Greicius MD, Yang TT, Glover GH, Reiss AL, et al. Comparison of fMRI activation at 3 and 1.5T during perceptual, cognitive, and affective processing. Neuroimage. 2003;18:813–26.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  71. 71.

    Day GS, Musiek ES, Roe CM, Norton J, Goate AM, Cruchaga C, et al. Phenotypic similarities between late-onset autosomal dominant and sporadic alzheimer disease: a single-family case-control study. JAMA Neurol. 2016;73:1125–32.

    PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain. 2018;141:1486–500.

    PubMed  Article  Google Scholar 

  73. 73.

    Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, et al. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther. 2011;3:1.

    PubMed  PubMed Central  Article  Google Scholar 

  74. 74.

    Joshi A, Ringman JM, Lee AS, Juarez KO, Mendez MF. Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease. J Neurol. 2012;259:2182–8.

    PubMed  PubMed Central  Article  Google Scholar 

  75. 75.

    Villemagne VL, Ataka S, Mizuno T, Brooks WS, Wada Y, Kondo M, et al. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol. 2009;66:1537–44.

    PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4:452–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  77. 77.

    Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol. 2006;253:139–58.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  78. 78.

    Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389–404.

    PubMed  PubMed Central  Article  Google Scholar 

  79. 79.

    Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, et al. Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals. J Neurosci. 2017;37:4323–31.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  80. 80.

    Marquie M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol. 2015;78:787–800.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  81. 81.

    Mackay CP, Kuys SS, Brauer SG. The effect of aerobic exercise on brain-derived neurotrophic factor in people with neurological disorders: a systematic review and meta-analysis. Neural Plast. 2017;2017:4716197.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  82. 82.

    Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. 2004;20:2580–90.

    PubMed  Article  PubMed Central  Google Scholar 

  83. 83.

    Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol. 2009;5:311–22.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

Download references

Funding

This project was supported by The Dominantly Inherited Alzheimer’s Network (DIAN, UF1 AG032438) funded by the National Institute on Aging (NIA), the German Center for Neurodegenerative Diseases (DZNE), the NIHR Queen Square Dementia Biomedical Research Centre and the MRC Dementias Platform UK (MR/L023784/1 and MR/009076/1), and AMED under grant number JP17dk0207036 and JP17kk0205009. This manuscript has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. We acknowledge the altruism of the participants and their families and contributions of the DIAN research and support staff at each of the participating sites for their contributions to this study. The FACEHBI study is supported by Grifols®, Piramal®, Araclon Biotech®, Laboratorios Echevarne S.A. and Fundació ACE, Institut Català de Neurociències Aplicades. M.E.—Alzheimer Forschung Initiative & LMU excellent; J.C.—K23AG049087; B.A.G.—K01AG053474, Barnes-Jewish Hospital Foundation Willman Scholar Fund; Y.Y.L.—National Health and Medical Research Council (NHMRC) GNT1111603, GNT1147465.

Author information

Affiliations

  1. Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany

    Nicolai Franzmeier, Jinyi Ren, Alexander Damm, Katharina Buerger, Marco Duering, Martin Dichgans, Daniel Janowitz, Cihan Catak, Miguel Ángel Araque Caballero & Michael Ewers

  2. Fundació ACE, Alzheimer Treatment and Research Center, Barcelona, Spain

    Gemma Monté-Rubio, Mercè Boada, Agustín Ruiz, Octavio Rodríguez Gómez & Sonia Moreno-Grau

  3. CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, National Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain

    Mercè Boada, Agustín Ruiz, Octavio Rodríguez Gómez & Sonia Moreno-Grau

  4. Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany

    Alfredo Ramirez, Frank Jessen & Esther Milz

  5. Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Bonn, Germany

    Alfredo Ramirez, Steffen Wolfsgruber, Michael Wagner, Frederic Brosseron, Klaus Fliessbach, Michael T. Heneka, Anja Schneider & Christine Westerteicher

  6. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

    Frank Jessen, Steffen Wolfsgruber, Michael Wagner, Annika Spottke, Henning Boecker, Frederic Brosseron, Klaus Fliessbach, Michael T. Heneka, Anja Schneider & Christine Westerteicher

  7. German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany

    Emrah Düzel, Peter Nestor, Oliver Speck, Coraline Metzger & Daniel Bittner

  8. Department of Radiology, Washington University in St Louis, St Louis, MO, USA

    Tammie Benzinger

  9. Knight Alzheimer’s Disease Research Center, Washington University in St. Louis, St. Louis, MO, USA

    Tammie Benzinger, Celeste M. Karch, Anne M. Fagan, Brian A. Gordon, John C. Morris & Randall J. Bateman

  10. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Alison Goate

  11. Ronald M. Loeb Center for Alzheimer’s Disease, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Alison Goate

  12. Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO, USA

    Celeste M. Karch & Anne M. Fagan

  13. Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA

    Celeste M. Karch & John C. Morris

  14. Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA

    Anne M. Fagan, Eric McDade, Jason Hassenstab, John C. Morris & Randall J. Bateman

  15. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany

    Katharina Buerger, Johannes Levin, Martin Dichgans, Marc Suárez-Calvet, Christian Haass, Robert Perneczky & Miguel Ángel Araque Caballero

  16. Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany

    Johannes Levin & Adrian Danek

  17. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

    Martin Dichgans & Robert Perneczky

  18. Barcelonabeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Catalonia, Spain

    Marc Suárez-Calvet

  19. Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany

    Marc Suárez-Calvet & Christian Haass

  20. Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO, USA

    Brian A. Gordon

  21. Department of Psychological and Brain Sciences, Washington University, St. Louis, MO, USA

    Brian A. Gordon

  22. The Florey Institute, The University of Melbourne, Parkville, VIC, Australia

    Yen Ying Lim & Colin L. Masters

  23. German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany

    Stefan Teipel, Michel J Grothe & Ingo Kilimann

  24. Department of Psychosomatic Medicine, University Hospital Rostock, Rostock, Germany

    Stefan Teipel

  25. Dementia Research Centre, University College London, Queen Square, London, UK

    Martin Rossor & Nick Fox

  26. Hertie Institute for Clinical Brain Research, Tübingen, Germany

    Christoph Laske

  27. Germany and German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

    Christoph Laske

  28. Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, MA, USA

    Jasmeer Chhatwal

  29. Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität München, Munich, Germany

    Peter Falkai & Robert Perneczky

  30. Neuroepidemiology and Ageing Research Unit, School of Public Health, The Imperial College of Science, Technology and Medicine, London, UK

    Robert Perneczky

  31. Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

    Jae-Hong Lee

  32. Department of Neurology, University of Bonn, Bonn, Germany

    Annika Spottke

  33. Department of Radiology, University of Bonn, Bonn, Germany

    Henning Boecker

  34. Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia

    Peter Nestor

  35. German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany

    Oliver Peters, Manuel Fuentes, Felix Menne, Josef Priller, Eike J. Spruth & Christiana Franke

  36. Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany

    Oliver Peters, Manuel Fuentes & Felix Menne

  37. Department of Neuropsychiatry, Charité, Berlin, Germany

    Josef Priller, Eike J. Spruth & Christiana Franke

  38. Leibniz Institute for Neurobiology, Magdeburg, Germany

    Oliver Speck

  39. Center for Behavioral Brain Sciences, Magdeburg, Germany

    Oliver Speck

  40. Department for Biomedical Magnetic Resonance, Institute for Physics, Otto-von-Guericke University, Magdeburg, Germany

    Oliver Speck

  41. German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany

    Jens Wiltfang

  42. Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany

    Jens Wiltfang & Claudia Bartels

  43. iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal

    Jens Wiltfang

  44. Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA

    Stephen Salloway

  45. Department of Nuclear Medicine, Technical University of Munich, Munich, Germany

    Igor Yakushev

  46. Neuroscience Research Australia, Barker Street Randwick, Sydney, NSW, 2031, Australia

    Peter R. Schofield

  47. School of Medical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia

    Peter R. Schofield

Authors
  1. Nicolai Franzmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinyi Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Damm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gemma Monté-Rubio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mercè Boada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Agustín Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alfredo Ramirez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Frank Jessen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Emrah Düzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Octavio Rodríguez Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tammie Benzinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Alison Goate
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Celeste M. Karch
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Anne M. Fagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Eric McDade
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Katharina Buerger
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Johannes Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Marco Duering
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Martin Dichgans
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Marc Suárez-Calvet
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Christian Haass
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Brian A. Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Yen Ying Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Colin L. Masters
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Daniel Janowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Cihan Catak
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Steffen Wolfsgruber
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Michael Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Esther Milz
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. Sonia Moreno-Grau
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. Stefan Teipel
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. Michel J Grothe
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. Ingo Kilimann
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. Martin Rossor
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. Nick Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

  36. Christoph Laske
    View author publications

    You can also search for this author in PubMed Google Scholar

  37. Jasmeer Chhatwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  38. Peter Falkai
    View author publications

    You can also search for this author in PubMed Google Scholar

  39. Robert Perneczky
    View author publications

    You can also search for this author in PubMed Google Scholar

  40. Jae-Hong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  41. Annika Spottke
    View author publications

    You can also search for this author in PubMed Google Scholar

  42. Henning Boecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  43. Frederic Brosseron
    View author publications

    You can also search for this author in PubMed Google Scholar

  44. Klaus Fliessbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  45. Michael T. Heneka
    View author publications

    You can also search for this author in PubMed Google Scholar

  46. Peter Nestor
    View author publications

    You can also search for this author in PubMed Google Scholar

  47. Oliver Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  48. Manuel Fuentes
    View author publications

    You can also search for this author in PubMed Google Scholar

  49. Felix Menne
    View author publications

    You can also search for this author in PubMed Google Scholar

  50. Josef Priller
    View author publications

    You can also search for this author in PubMed Google Scholar

  51. Eike J. Spruth
    View author publications

    You can also search for this author in PubMed Google Scholar

  52. Christiana Franke
    View author publications

    You can also search for this author in PubMed Google Scholar

  53. Anja Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  54. Christine Westerteicher
    View author publications

    You can also search for this author in PubMed Google Scholar

  55. Oliver Speck
    View author publications

    You can also search for this author in PubMed Google Scholar

  56. Jens Wiltfang
    View author publications

    You can also search for this author in PubMed Google Scholar

  57. Claudia Bartels
    View author publications

    You can also search for this author in PubMed Google Scholar

  58. Miguel Ángel Araque Caballero
    View author publications

    You can also search for this author in PubMed Google Scholar

  59. Coraline Metzger
    View author publications

    You can also search for this author in PubMed Google Scholar

  60. Daniel Bittner
    View author publications

    You can also search for this author in PubMed Google Scholar

  61. Stephen Salloway
    View author publications

    You can also search for this author in PubMed Google Scholar

  62. Adrian Danek
    View author publications

    You can also search for this author in PubMed Google Scholar

  63. Jason Hassenstab
    View author publications

    You can also search for this author in PubMed Google Scholar

  64. Igor Yakushev
    View author publications

    You can also search for this author in PubMed Google Scholar

  65. Peter R. Schofield
    View author publications

    You can also search for this author in PubMed Google Scholar

  66. John C. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  67. Randall J. Bateman
    View author publications

    You can also search for this author in PubMed Google Scholar

  68. Michael Ewers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Ewers.

Ethics declarations

Conflict of interest

A.M.F. has received research funding from Biogen, Fujirebio, and Roche Diagnostics. She is a member of the scientific advisory boards for Roche, Genentech, and AbbVie and also consults for Araclon/Griffols and DiamiR.: Y.Y.L. has served as a scientific consultant to Biogen and Lundbeck; M.B. who has consulted or advisory board for Araclon, Grifols, Lilly, Nutricia, Roche and Servier. She received fees for lectures and funds for research from Araclon, Grifols, Nutricia, Roche and Servier. She has not received personal compensations from these organizations. A. Ruiz has consulted for Grifols and Landsteiner Genmed. He received funds for research and/or reimbursement of expenses for congresses attendance from Araclon, and Grifols. He has not received personal compensations from these organizations: T.B., Investigator, initiated research funding sponsored by Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly) and Foundation for the NIH. Clinical trials sponsored by Avid Radiopharmaceuticals, Eli Lilly, Roche, Jaansen, Biogen, and NIH. Travel sponsored by the American Society for Neuroradiology, Alzheimer’s Association International Convention, NIH. The remaining authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Franzmeier, N., Ren, J., Damm, A. et al. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease. Mol Psychiatry (2019). https://doi.org/10.1038/s41380-019-0404-6

Download citation

Further reading

Search

Quick links